A pro-inflammatory gut microbiota-metabolic axis in global developmental delay identified by integrated multi-omics

Global developmental delay (GDD) affects 1–3% of children, yet its etiology remains undetermined in 40–50% of cases despite comprehensive genetic testing. The role of the gut-brain axis in GDD is poorly defined, partly due to prior studies’ reliance on relative microbial abundance metrics. In this hypothesis-generating pilot cross-sectional study, we applied an integrated multi-omics framework combining absolute quantitative 16S rRNA gene sequencing with untargeted metabolomics to characterize the gut ecosystem in 16 young children with GDD (aged ≤3 years) and 20 age-matched healthy controls. Absolute quantification revealed significant enrichment of a pro-inflammatory consortium in the GDD gut microbiome, most notably the Ruminococcus gnavus group (2.15-fold increase, p < 0.05). Untargeted metabolomics identified Ethyl Diethanolamine as the top discriminant metabolite, markedly depleted in the GDD group (FC = 0.73, p < 0.0001). Pathway analysis pinpointed tryptophan metabolism as the most significantly perturbed pathway ( p < 0.001), characterized by a complex, multi-directional shift involving simultaneous upregulation of kynurenine, melatonin, and microbial indole metabolites. Multi-omics integration revealed strong overall microbiota-metabolome concordance alongside GDD-specific disruptions in fine-scale correlation networks. These pilot data suggest a pro-inflammatory gut microbiota–metabolite axis in GDD, potentially driven by expansion of R. gnavus and disruption of tryptophan metabolism. Ethyl Diethanolamine depletion emerges as a novel candidate biomarker, warranting future validation in larger cohorts.

Authors

Institutions

Publication Details

Journal
Translational Psychiatry
Published
2026-11-20
DOI
https://doi.org/10.1038/s41398-026-04420-9
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A pro-inflammatory gut microbiota-metabolic axis in global developmental delay identified by integrated multi-omics

Congfu Huang, Lingyu Wan, Haiying Liu, Jindou Hao et al.
1 links
Translational Psychiatry
Gut microbiota and health
article

A pro-inflammatory gut microbiota-metabolic axis in global developmental delay identified by integrated multi-omics

Congfu Huang, Lingyu Wan, Haiying Liu, Jindou Hao, Meifen Li, Yongmei Zeng
article en

Abstract

Global developmental delay (GDD) affects 1–3% of children, yet its etiology remains undetermined in 40–50% of cases despite comprehensive genetic testing. The role of the gut-brain axis in GDD is poorly defined, partly due to prior studies’ reliance on relative microbial abundance metrics. In this hypothesis-generating pilot cross-sectional study, we applied an integrated multi-omics framework combining absolute quantitative 16S rRNA gene sequencing with untargeted metabolomics to characterize the gut ecosystem in 16 young children with GDD (aged ≤3 years) and 20 age-matched healthy controls. Absolute quantification revealed significant enrichment of a pro-inflammatory consortium in the GDD gut microbiome, most notably the Ruminococcus gnavus group (2.15-fold increase, p < 0.05). Untargeted metabolomics identified Ethyl Diethanolamine as the top discriminant metabolite, markedly depleted in the GDD group (FC = 0.73, p < 0.0001). Pathway analysis pinpointed tryptophan metabolism as the most significantly perturbed pathway ( p < 0.001), characterized by a complex, multi-directional shift involving simultaneous upregulation of kynurenine, melatonin, and microbial indole metabolites. Multi-omics integration revealed strong overall microbiota-metabolome concordance alongside GDD-specific disruptions in fine-scale correlation networks. These pilot data suggest a pro-inflammatory gut microbiota–metabolite axis in GDD, potentially driven by expansion of R. gnavus and disruption of tryptophan metabolism. Ethyl Diethanolamine depletion emerges as a novel candidate biomarker, warranting future validation in larger cohorts.

Translational Psychiatry
Shenzhen Maternity and Child Healthcare Hospital (CN), Southern Medical University (CN)
Sanming Project of Medicine in Shenzhen
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
A pro-inflammatory gut microbiota-metabolic axis in global developmental delay identified by integrated multi-omics — Congfu Huang, Lingyu Wan, et al. · Translational Psychiatry (2026) | TGRS Research Map | TGRS